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The Saccharomyces cerevisiae inositol sphingolipid phospholipase C (Isc1p), a homolog of mammalian neutral sphingomyelinases, hydrolyzes
complex sphingolipids to produce ceramide in vitro. Epitope-tagged Isc1p associates with themitochondria in the post-diauxic phase of yeast growth.
In this report, the mitochondrial localization of Isc1p and its role in regulating sphingolipid metabolism were investigated. First, endogenous Isc1p
activity was enriched in highly purified mitochondria, and western blots using highly purified mitochondrial membrane fractions demonstrated that
epitope-tagged Isc1p localized to the outer mitochondrial membrane as an integral membrane protein. Next, LC/MS was employed to determine the
sphingolipid composition of highly purified mitochondria which were found to be significantly enriched in α-hydroxylated phytoceramides (21.7
fold) relative to the whole cell. Mitochondria, on the other hand, were significantly depleted in sphingoid bases. Compared to the parental strain,
mitochondria from isc1Δ in the post-diauxic phase showed drastic reduction in the levels of α-hydroxylated phytoceramide (93.1% loss compared to
WT mitochondria with only 2.58 fold enrichment in mitochondria compared to whole cell). Functionally, isc1Δ showed a higher rate of respiratory-
deficient cells after incubation at high temperature and was more sensitive to hydrogen peroxide and ethidium bromide, indicating that isc1Δ exhibits
defects related to mitochondrial function. These results suggest that Isc1p generates ceramide in mitochondria, and the generated ceramide
contributes to the normal function of mitochondria. This study provides a first insight into the specific composition of ceramides in mitochondria.
© 2007 Elsevier B.V. All rights reserved.Keywords: Mitochondria; Sphingolipid; Sphingomyelinase; Lipidomics; ISC1; Yeast1. Introduction
Sphingolipids play crucial roles as signaling molecules in
eukaryotic cells, regulating such processes as stress responses,Abbreviations: IPC, inositol phosphorylceramide; MIPC, mannosylinositol
phosphorylceramide; M(IP)2C, mannosyldiinositol phosphorylceramide; YPD,
yeast/peptone/dextrose; YPGE, yeast/peptone/glycerol/ethanol; SEM, standard
error of mean; ER, endoplasmic reticulum; IS, internal standard; a-HO-, α-
hydroxylated; Cer, ceramide; DHSph, dihydrosphingosine; Phyto-Sph, phyto-
sphingosine; dhCn-Cer, dihydroceramide with Cn fatty acid; phytoCn-Cer,
phytoceramide with Cn fatty acid
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doi:10.1016/j.bbamem.2007.07.019cell growth, differentiation, cell cycle arrest, endocytosis, and
apoptosis [1–7]. Additionally, complex sphingolipids serve
structural functions in membranes, and they may also undergo
dynamic clustering with sterols to form lipid microdomains or
‘rafts’ within the membrane bilayer. This domain structure has
been proposed to play a role as platforms for signal transduction
and/or protein sorting [8].
Most, if not all, organelles contain sphingolipids as well as
several sphingolipid-metabolizing enzymes [9–11]. Moreover,
the hydrophobicity of bioactive sphingolipids restrains them to
their specific compartments (unless transported by specific
mechanisms). These considerations led to the proposal that
sphingolipid function is compartment-specific [1]. In this
2850 H. Kitagaki et al. / Biochimica et Biophysica Acta 1768 (2007) 2849–2861context, many studies in eukaryotes have recently started
suggesting important roles for mitochondrial sphingolipids
[11–13].
Ceramide in mitochondria has been shown to regulate
apoptosis in mammalian cells. For example, when bacterial
sphingomyelinase was targeted to mitochondria, it induced
mitochondrial ceramide generation and apoptosis [13], and
mitochondrial ceramide has been implicated in the activation/
translocation of the pro-apoptotic Bax [14]. Moreover, many
studies have reported that ceramide has biophysical effects on
mitochondrial membranes, by increasing the permeability of the
outer and inner mitochondrial membranes [15], suppressing
respiratory chain activity [16], or forming channels [17].
Therefore, the role of ceramide in mitochondria is attracting
wide interests in terms of basic biology and medical application.
Other studies have suggested mitochondrial localization of some
enzymes of sphingolipid metabolism, including ceramide and
dihydroceramide synthase [12,18], ceramidase [19], glycosyl-
transferase [20], human sialidase [21], and sphingosine kinase
[22].
Saccharomyces cerevisiae has proven to be an invaluable
model for studying sphingolipid biosynthesis, in part because of
its simplicity in sphingolipid metabolism relative to mammalian
systems [3,23]. Interestingly, the S. cerevisiae Isc1p, the homo-
log of mammalian neutral sphingomyelinases, was recently
shown to associate with mitochondria in the post-diauxic phase
of yeast growth [24]. Isc1p produces ceramide from the
complex sphingolipids inositol phosphorylceramide (IPC),
mannosylinositol phosphorylceramide (MIPC), and mannosyl-
diinositol phosphorylceramide (M(IP)2C) [25–28]. Isc1p was
also shown to have a role in utilization of non-fermentable
carbon sources, as an isc1Δ strain grew very slowly in the post-
diauxic phase or when grown in media containing non-
fermentable carbon sources [29]. Utilization of non-fermentable
carbon sources requires intact mitochondrial function, thus
suggesting a role for Isc1p in mitochondrial function.
In this study we sought to elucidate the submitochondrial
localization of Isc1p, its role in mitochondrial sphingolipid
metabolism, and mitochondria-related phenotypes of isc1Δ.
These studies have implications for compartment-specific
sphingolipid metabolism and function in vivo.
2. Materials and methods
2.1. Yeast strains and media
JK93αWT (MATα leu2-3, 112 ura3-52 rme1 trp1 his4) and JK93α isc1Δ
(MATα leu2-3, 112 ura3-52 rme1 trp1 his4 ISC1::G418) [25] were used in this
study. Standard yeast culture medium was prepared using Difco YPD broth.
Plates were prepared using Difco YPD agar and stored at 4 °C. YPGE plates
contained 1% yeast extract, 2% bactopeptone, 2% ethanol, 2% glycerol and 2%
agar. Yeast cells were cultured at 30 °C with shaking unless otherwise
indicated.
2.2. Isolation of purified mitochondria
Isolation of purified mitochondria was basically performed essentially as
described [30–32]. Briefly, yeast cells were incubated to saturation at 30 °C.
Six-liter flask containing approximately 1.25 L YPD were inoculated with anovernight culture to OD600=0.1 and incubated at 30 °C for 24 h with vigorous
aeration. Yeast cells were centrifuged at 2000×g for 5 min, washed with water,
resuspended in 100 mM Tris–SO4, pH 9.4, 10 mM DTT (2 ml/g wet cell),
incubated at 30 °C for 15 min, centrifuged at 2000×g for 5 min, washed with SP
buffer (1.2 M sorbitol, 20 mM K-P pH 7.4), dissolved in SP buffer containing
zymolyase 100T (7 ml/g cells, 1.5 mg/g cells), incubated at 30 °C for 60 min,
centrifuged at 2500×g for 5 min, washed with SP buffer (7 ml/g wet cell) twice,
resuspended in homogenization buffer (0.6 M sorbitol, 10 mM Tris–HCl, pH
7.4, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride) (6.5 ml/g cells),
homogenized in a 40 ml dounce homogenizer coated with Teflon using 25
strokes, diluted two fold with homogenizing buffer, centrifuged for 5 min at
1500×g to remove cell nuclei and debris, and centrifuged again at 2500×g for
5 min. The supernatant was centrifuged at 12,000×g for 15 min. The supernatant
was saved as the post-mitochondrial fraction and TCA-precipitated for further
analysis. The pellet was resuspended in 30 ml SM buffer (250 mM sucrose,
1 mM EDTA, 10 mM MOPS-KOH, pH 7.2) and centrifuged at 2500×g for
5 min. The supernatant was then centrifuged at 12,000×g for 15 min, and the
pellet was resuspended in 10 ml SM buffer as crude mitochondria. For
purification of mitochondria, the amount of mitochondrial protein was measured
by OD280, adjusted to 5 mg/ml protein in SM buffer, homogenized with 10
strokes in a dounce homogenizer coated with Teflon, and subsequently loaded
onto a four-step sucrose gradient [1.5 ml of 60%, 4 ml of 32%, 1.5 ml of 23%,
1.5 ml of 15% of sucrose in 1 mM EDTA, 10 mM MOPS-KOH (pH 7.2)], and
centrifuged at 134,000×g for 1 h with no braking. The 32/60% interface was
then recovered with a Pasteur pipette and washed with 2 vol of SM buffer at
12,000×g for 15 min. The mitochondrial fraction was again homogenized with
10 strokes in a dounce homogenizer coated with Teflon and then applied to a
four-step sucrose gradient as described above. The 32/60% interface was re-
covered, resuspended in 2 volumes of SM buffer, and centrifuged at 12,000×g
for 15 min. The final pellet was resuspended in SM buffer, divided into small
aliquots, and frozen at −80 °C.
2.3. LC/MS measurements
Purified mitochondria or yeast cells in the post-diauxic phase were snap-
frozen in a methanol-dry ice bath and stored at −80 °C. ESI/MS/MS analysis of
endogenous phyto- and dihydrosphingosine bases, their phosphates, α-
hydroxylated phytoceramide, and non-hydroxylated phyto- and dihydrocer-
amide species were performed on a Thermo Finnigan TSQ 7000 triple
quadrupole mass spectrometer, operating in a Multiple Reaction Monitoring
positive ionization mode, using modified version [28,34]. Briefly, biological
samples were fortified with internal standards (ISs: C17 base D-erythro-
sphingosine, C17 sphingosine-1-phosphate, N-palmitoyl-D-erythro-C13 sphin-
gosine, heptadecanoyl-D-erythro-sphingosine and C6-Phyto-ceramide), then
extracted with 70% isopropanol:ethylacetate:pyridine:25% ammonia
(60:20:2:0.5 by volume) solvent system. After evaporation and reconstitution
in 150 μl of methanol, samples were injected on the HP1100/TSQ 7000 LC/MS
system and gradient eluted from the BDS Hypersil C8, 150×3.2 mm, 3 μm
particle size column, with 1.0 mM methanolic ammonium formate/2 mM
aqueous ammonium formate mobile phase system. Peaks corresponding to the
target analytes and ISs were collected and processed using the Xcalibur
software system. Quantitative analysis was based on the calibration curves
generated by spiking an artificial matrix with the known amounts of the target
analyte synthetic standards and an equal amount of IS. The target analyte/IS
peak area ratios were plotted against analyzed concentration. The target
analyte/IS peak area ratios from the samples were similarly normalized to their
respective ISs and compared to the calibration curves, using a linear regression
model.
2.4. Submitochondrial localization of Flag-Isc1p
Submitochondrial localization of Flag-Isc1p was determined as previously
described [35]. Briefly, 200 μg of highly purified mitochondria from isc1Δ +
pYES/FLAG-ISC1 were pelleted at 10,000×g for 15 min and suspended in 40 μl
SM buffer (250 mM sucrose, 1 mM EDTA, 10 mM MOPS-KOH, pH 7.2).
Samples were split into two equal portions. One hundred and eighty microliters
of SM buffer or EM buffer (1 mM EDTA, 10 mM MOPS-KOH, pH 7.2) was
added, pipetted up and down 10 times to facilitate the rupture of the outer
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Samples were split into two equal portions and treated with or without 50 μg/ml
proteinase K for 30 min on ice. Phenylmethylsulfonyl fluoride was added to the
solution (final concentration 2 mM). The sample was then centrifuged at
12,000×g for 5 min, washed once and analyzed by western blotting using anti-
Flag antibody.
2.5. Determination of association of proteins with membrane
Highly purified mitochondria, purified from isc1Δ +pYES/FLAG-ISC1,
were treated without osmotic shock (250 mM sucrose, 10 mM HEPES, pH 7.2,
1 mM EDTA), with osmotic shock (10 mMHEPES, pH 7.2, 1 mM EDTA), with
osmotic shock and high salt (0.1MNaCl, 10mMHEPES, pH 7.2, 1 mMEDTA),
or with osmotic shock and alkali pH (0.1 M Na2CO3, pH 11.2, 10 mM HEPES,
pH 7.2, 1 mM EDTA). They were then centrifuged at 100,000×g for 10 min, and
the pellet and supernatant were analyzed by western blotting using antibody
against Flag.
2.6. Statistical analysis
The amounts of sphingolipid species of mitochondria prepared fromWTand
isc1Δ are presented as means±standard error of the mean (SEM) of three lipid
measurements from two independent cultures and mitochondrial purifications.
The amounts of sphingolipid species of the whole cell are presented as means±
SEM of lipid measurements from three independent cultures. Statistical
differences were evaluated by Student's unpaired t test.
2.7. Miscellaneous
Antibodies against Cox3p, Porin, Dpm1p, V-ATPase (100 kDa subunit), and
Pgk1p were obtained from Molecular Probes, and that against FLAG was from
Sigma-Aldrich. The antibody againstMge1pwas a kind gift fromDr. C.M.Koehler.3. Results
3.1. Isc1p as an integral membrane protein localized to the
outer membrane of mitochondria
Since epitope-tagged Isc1p was previously shown to
associate with mitochondria in the post-diauxic phase, it
became important to determine the mitochondrial localization
of endogenous Isc1p. WT and isc1Δ cells were incubated to the
post-diauxic phase, collected by centrifugation, and mitochon-
dria were isolated to a high degree of purity using multi-step
centrifugation in conjunction with a two-step sucrose gradient,
which has been verified by mitochondrial proteome studies
[30–33]. The purity of the mitochondria was confirmed by
western blotting with an antibody against a cytosolic marker
protein, Pgk1p, a vacuolar marker protein, V-ATPase, an
endoplasmic reticulum (ER) marker protein, Dpm1p, and a
mitochondrial marker protein, Cox3p. The results showed that
the purified fraction was devoid of Pgk1p, V-ATPase and
Dpm1p and highly enriched in Cox3p (Fig. 1A), indicating that
mitochondria were purified to a high degree, consistent with
previous reports [30–32]. Subsequent studies were performed
using these highly purified mitochondria prepared from post-
diauxic phase cells. In order to determine the localization of
endogenous Isc1p, Isc1p enzymatic activity in the purified
mitochondria was determined. Isc1p specific activity was
highly concentrated in the mitochondrial fraction (2.8 pmol/
μg/h) when compared to the specific activity of the whole cellhomogenate (1.0 pmol/μg/h) (Fig. 1B). Moreover, cells and
mitochondria from the isc1Δ strain contained only background
activity, demonstrating the Isc1p is the primary enzyme
responsible for the detected activity in mitochondria. Taken
together, these results demonstrate that Isc1p activity is indeed
localized to mitochondria (Fig. 1B).
Next it became important to determine if Isc1p is loosely
associated with mitochondria or if it is an integral mitochondrial
membrane protein. Mitochondria were treated with osmotic
shock (to lyse the mitochondrial outer membrane) and then
treated with either high salt or alkali pH extraction, centrifuged
at 100,000×g for 10 min, and pellets were analyzed by western
blotting. N-terminally tagged Flag-Isc1p [25] was not dissoci-
ated from the membrane with osmotic shock (Fig. 1C lanes 4
and 5), high salt (Fig. 1C lanes 6 and 7) or alkali pH (Fig. 1C
lanes 8 and 9). Cox3p, a known integral membrane protein
behaved similarly whereas Mge1p, a peripheral mitochondrial
protein became significantly dissociated from membranes in
response to treatment with alkaline pH. Taken together, these
results indicate that Isc1p is a bona fide membrane protein.
Next, the submitochondrial localization of Isc1p was
determined using protease protection assays. Proteinase K was
added to purified mitochondria with or without osmotic shock,
and the degradation of several marker proteins was examined by
western blotting. Using this assay without osmotic shock,
exogenously added proteinase K can only access and degrade
proteins exposed from the outer mitochondrial membrane. On
the other hand, with osmotic shock, proteinase K causes
degradation of proteins contained in the outer membrane, in
the intermembrane space, or exposed out of the inner membrane
since osmotic shock causes rupture of the outer mitochondrial
membrane while leaving the inner mitochondrial membrane
intact. A previously characterized inner membrane protein,
Cox3p, was not degraded even after osmotic shock (Fig. 1D,
lane 4), demonstrating that under these conditions, no protease
cleavage sites are exposed out of the inner membrane. On the
other hand, porin, a marker protein for outer mitochondrial
membrane proteins, was degraded only after osmotic shock
(Fig. 1D, lane 4), suggesting that it is inserted in the outer
membrane so that it is degraded only after rupture of the outer
membrane. To the contrary, Flag-Isc1p was efficiently degraded
even without osmotic shock (Fig. 1D, lane 2), indicating that
Flag-Isc1p localized to the outer membrane of mitochondria
with exposed protease cleavage sites, or, alternatively, only N-
terminally tagged FLAG is exposed from the outer membrane
and Isc1p is localized inside the outer membrane. From all the
above data, it could be concluded that Flag-Isc1p localizes to the
outer membrane of mitochondria and is integrated into the outer
mitochondrial membrane.
3.2. Mitochondria are enriched in very long chain phytoceramides
In previous reports, we showed that Isc1p degrades complex
sphingolipids such as IPC, MIPC and M(IP)2C to form
ceramides in vitro [25–27] and that Isc1p is activated by
phosphatidylglycerol and cardiolipin [29], two phospholipids
that reside in mitochondria [36,37]. These results, together with
2852 H. Kitagaki et al. / Biochimica et Biophysica Acta 1768 (2007) 2849–2861the mitochondrial localization of Isc1p, raised the possibility
that Isc1p may be responsible for generation of ceramides in
mitochondria in vivo. To address this issue, we first determinedthe sphingolipid composition of mitochondria and compared it
to that of whole cells. WT cells were incubated to the post-
diauxic phase, and the mitochondria were isolated to a high
Fig. 2. Sphingolipid profile of WT cells. WT cells were incubated to the post-diauxic phase. Sphingolipids were analyzed by LC-MS and normalized by organic
phosphates as described in Materials and methods. (A) Species which are more than 0.040 pmol/nmol organic phosphate, (B) species which are more than
0.0050 pmol/nmol organic phosphate but less than 0.040 pmol/nmol organic phosphate, and (C) species which are less than 0.0050 pmol/nmol organic phosphate of
the whole cell of WT. The results are mean values±SEM of lipid measurements from three independent cultures.
2853H. Kitagaki et al. / Biochimica et Biophysica Acta 1768 (2007) 2849–2861degree of purity using a two-step sucrose gradient as described
above. The sphingolipid profile of the whole cell of WT and the
mitochondria purified from WT was determined using LC-MS
[34]. The masses of sphingolipids were calculated based on the
phospholipid content.
In whole cells, α-hydroxylated C26-phytoceramide, phyto-
sphingosine, dihydrosphingosine, and α-hydroxylated C14-
phytoceramide constituted the major species (Fig. 2A),
α-hydroxylated C24:1-, C24- and C18-phytoceramides and non-Fig. 1. Purification of mitochondria and submitochondrial fractionation of Flag-Isc1p
(lanes 1, 5: total cell lysate; lanes 2, 6: post-mitochondrial fraction; lanes 3, 7: crude
isc1Δ (lanes 5–8) were subjected to western blotting against a cytosolic protein, P
mitochondrial membrane protein, Cox3p. (B) Isc1p activity of purified mitochondria
was measured basically as previously described (24). (C) Membrane association of
without osmotic shock (lanes 2, 3: 250 mM sucrose, 10 mM HEPES, pH 7.2, 1 mM
with osmotic shock and high salt (lanes 6, 7: 0.1 M NaCl, 10 mM HEPES, pH 7.2, 1 m
11.2, 10 mMHEPES, pH 7.2, 1 mMEDTA), centrifuged at 100,000×g for 10 min, and
analyzed by western blotting using an antibody against Flag. (D) Submitochondrial lo
were treated without osmotic shock (lanes 1, 2; 250 mM sucrose, 10 mM HEPES, pH
1 mM EDTA) for 10 min on ice and with (lanes 2, 4) or without (lanes 1, 3) final 50
added, mitochondria were centrifuged at 12,000×g for 5 min, washed once, and pellehydroxylated C26-phytoceramides were next in abundance (Fig.
2B), andα-hydroxylated C20- and C22-phytoceramides andmost
of the non-hydroxylated dihydroceramides and phytoceramides
showed significantly lower levels (Fig. 2C).
In contrast, the results revealed, for the first time, that
mitochondria contain predominantly α-hydroxylated C26-phy-
toceramide (Fig. 3A) with significantly lower levels of other
ceramides or sphingoid bases (Fig. 3B and C). These results
were expressed relative to mitochondrial total phospholipids,. (A) Validation of the purity of mitochondria. Forty micrograms of each sample
mitochondria and lanes 4, 8: purified mitochondria) from WT (lanes 1–4) and
gk1p, a vacuolar protein, V-ATPase, an ER membrane protein, Dpm1p, and a
. Isc1p activity of purified mitochondria and the whole cell from WT and isc1Δ
Flag-Isc1p. Mitochondria purified from isc1Δ +pYES/FLAG-ISC1 were treated
EDTA), with osmotic shock (lanes 4, 5: 10 mM HEPES, pH 7.2, 1 mM EDTA),
M EDTA), or with osmotic shock and alkali pH (lanes 8, 9: 0.1 M Na2CO3, pH
total (lane 1), membrane (lanes 2, 4, 6, 8), and supernatant (lanes 3, 5, 7, 9) were
calization of Flag-Isc1p. Mitochondria purified from isc1Δ +pYES/FLAG-ISC1
7.2, 1 mM EDTA) or with osmotic shock (lanes 3, 4; 10 mM HEPES, pH 7.2,
μg/ml proteinase K for 30 min on ice. 2 mM phenylmethylsulfonyl fluoride was
ts were applied to western analysis with antibody against Flag, porin, or Cox3p.
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2855H. Kitagaki et al. / Biochimica et Biophysica Acta 1768 (2007) 2849–2861and therefore, they represent the relative surface concentration
of these sphingolipids in membranes. It should be noted that
even for the highest ceramide, the ratio to phospholipids was
less than 3%, thus demonstrating that phospholipids are indeed
in excess and that mitochondrial ceramides are minor species.
In order to determine the relative enrichment of mitochon-
drial ceramides to that of whole cells, we calculated the degree of
‘surface enrichment’ of these sphingolipids in mitochondria to
whole cells by dividing the ceramide/phospholipid ratio in
mitochondria over that in whole cells. This calculated ratio of
mitochondrial/whole cell for α-hydroxylated C26-phytocera-
mides was 21.7 fold, and this enrichment in mitochondria was
also observed for other ceramide species (Fig. 3D), indicating
that mitochondria were highly enriched with ceramide species
mainly composed of α-hydroxylated phytoceramides. This
result also suggests that the major source of α-hydroxylated
phytoceramides of the whole cell is derived from the
mitochondria. Non-hydroxylated ceramides also showed
increases in the mitochondria relative to the whole cells (Fig.
3D). Notably, the levels of the non-hydroxylated phytocera-
mides and dihydroceramides were significantly lower than those
of α-hydroxylated phytoceramides both in whole cells and
mitochondria (Figs. 2 and 3).
Reciprocally, the levels of phytosphingosine, the predomi-
nant ‘simple’ sphingolipid of yeast, were significantly decreased
in mitochondria relative to whole cells (Fig. 3E, note inverted
y-axis compared to 3D).
Taken together, the results demonstrate that in S. cerevisiae,
mitochondria show selective enrichment in α-hydroxylated
phytoceramides and selective depletion of sphingoid bases.
These results were basically similar when sphingolipid levels
were normalized by protein amount (data not shown), indicating
that these results are not due to selective difference in total
phospholipid levels between the whole cell and mitochondria.
3.3. Mitochondria of isc1Δ show an altered sphingolipid profile
Next, the sphingolipid profile of mitochondria prepared from
isc1Δ was determined and compared to that of WT mitochon-
dria in order to determine the contribution of Isc1p to mitochon-
drial sphingolipids. The major sphingolipids detected in whole
cells of the isc1Δ strain were α-hydroxylated C26-phytocer-
amide, phytosphingosine, α-hydroxylated C14-phytoceramide
and dihydrosphingosine (Fig. 4A) followed by non-hydroxyl-
ated C26-phytoceramide, α-hydroxylated C24-phytoceramide
and non-hydroxylated C18:1-dihydroceramide (Fig. 4B), with
other ceramides showing very low levels (Fig. 4C).
The predominant species of sphingolipids in mitochondria
from isc1Δ were α-hydroxylated C26-phytoceramide, non-Fig. 3. Sphingolipid profile of WT mitochondria. WT cells were incubated to the po
methods. Sphingolipids were analyzed by LC-MS and normalized by organic phosp
0.040 pmol/nmol organic phosphate, (B) species which are more than 0.0050 pmol/
(C) species which are less than 0.0050 pmol/nmol organic phosphate of the WT mito
two independent mitochondrial purifications. Mitochondrial sphingolipids were divid
of mitochondrial sphingolipids to the sphingolipids of the whole cell. Sphingolipids
the whole cell to mitochondrial sphingolipids. Sphingolipids that were decreased inhydroxylated C26-phytoceramide, α-hydroxylated C14-phyto-
ceramide and α-hydroxylated C24:1-phytoceramide (Fig. 4D),
followed by α-hydroxylated C24-phytoceramide, non-hydrox-
ylated C26:1-phytoceramide, phytosphingosine and dihydro-
sphingosine (Fig. 4E), with other sphingolipids being minor
species (Fig. 4F).
Many of these species showed significant reduction in their
enrichment in mitochondria. Most notably, the content of α-
hydroxylated C26-phytoceramide in isc1Δ mitochondria was
only 6.94% of that of WT mitochondria (Fig. 5A), and this
decrease was significantly rescued by expression of FLAG-
ISC1 (Fig. 5C). As a consequence, the enrichment of α-
hydroxylated C26-phytoceramide in mitochondria was de-
creased to 2.58 fold in isc1Δ (Fig. 4A and D) relative to the
21.7 fold in WT (Fig. 3D). This decrease in isc1Δ mitochondria
was also observed for other ceramides (Fig. 5A).
These results suggest that Isc1p functions in cells to generate
mitochondrial ceramides mainly composed of α-hydroxylated
phyotceramides. Reciprocally, α-hydroxylated C14-phytocera-
mide and non-hydroxylated C26-phytoceramide were increased
in isc1Δ mitochondria (Fig. 5B), suggesting a complementary
pathway to overcome the decrease of other ceramide species.
These lipid changes in isc1Δ mitochondria were partially
suppressed by the expression of FLAG-ISC1 (Fig. 5C),
although some of the lipids were not recovered to 100%,
probably because FLAG-ISC1 was expressed under the GAL1
promoter. Nonetheless, this result indicates that the lipid
changes observed in isc1Δ mitochondria relative to WT
mitochondria are not derived from artifact of mitochondrial
purification. Phospholipid content per protein in WT mitochon-
dria was 34.9±3.14 (nmol/mg), while that in isc1Δ mitochon-
dria is 36.7±0.96 (nmol/mg), indicating that the mass profile
changes induced by the deletion of ISC1 are not due to
phospholipid changes in the mitochondria of isc1Δ. These
results demonstrate that the isc1Δ has an altered mitochondrial
sphingolipid profile, and suggest that Isc1p produces selectively
α-hydroxylated phytoceramides in mitochondria in vivo.
3.4. Disruption of ISC1 induces mitochondrial-associated
defects
The alteration of sphingolipid profile of mitochondria in vivo
observed above suggested that Isc1p may influence mitochon-
drial related functions. In order to address this hypothesis, we
examined the formation of petite colonies in isc1Δ. In S.
cerevisiae, mitochondrial defects often manifest by growing as
respiratory deficient, “petite” colonies on fermentable carbon
sources. In addition, cells with compromised mitochondria form
large numbers of petite colonies after prolonged culture atst-diauxic phase, and mitochondria were purified as described in Materials and
hates as described in Materials and methods. (A) Species which are more than
nmol organic phosphate but less than 0.040 pmol/nmol organic phosphate, and
chondria. The results are mean values±SEM of three lipid measurements from
ed by the amount of sphingolipids in the whole cell analyzed in Fig. 2. (D) Ratio
that were increased in mitochondria are shown. (E) Ratio of the sphingolipids in
mitochondria are shown.
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Fig. 5. Comparison of mitochondrial sphingolipids of isc1Δ with those of WT. The relative amounts of individual mitochondrial sphingolipids of isc1Δ and isc1Δ +
pYES/FLAG-ISC1 were compared with those of WT. (A) Ratio of the sphingolipids in WT relative to those in isc1Δ. Sphingolipids that were decreased in isc1Δ are
shown. (B) Ratio of the sphingolipids in isc1Δ relative to those inWT. Sphingolipids that were increased in isc1Δ are shown. (C) Ratio of the sphingolipids in isc1Δ and
isc1Δ +pYES/FLAG-ISC1 relative to those in WT.
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fermentable carbon sources [38,39]. To determine whether
isc1Δ would form petites under these conditions, the isc1Δ
strain was grown at normal (30 °C) and high temperature
(39 °C), and the fraction of petite colonies was determined by
counting the ratio of colonies which have smaller size than
normal and are unable to grow on non-fermentable carbon
source plates (YPGE). The results showed that the isc1Δ strainFig. 4. Sphingolipid profile of isc1Δ. isc1Δ cells were incubated to the post-diauxic
described in Materials and methods. Sphingolipids were analyzed by LC-MS as de
Species which are more than 0.040 pmol/nmol organic phosphate, (B) species which
nmol organic phosphate, (C) species which are less than 0.0050 pmol/nmol organic p
organic phosphate, (E) species which are more than 0.0050 pmol/nmol organic phosp
less than 0.0050 pmol/nmol organic phosphate of isc1Δ mitochondria. The results ar
the whole cell analysis, or, three lipid measurements from two independent mitochoexhibited a significantly increased ratio of petite colonies at
normal temperature ( pb0.01, Fig. 6A) and this phenotype was
significantly exacerbated by growth at high temperature
( pb0.12, Fig. 6A).
Yeast cells with compromised mitochondria have also been
shown to be sensitive to oxidative stress such as hydrogen
peroxide [40]. To test whether the isc1Δ strain was sensitive to
hydrogen peroxide, yeast in log phase growth were treated withphase, and collected for whole cell analyses or for mitochondrial purification as
scribed in Materials and methods, and normalized by organic phosphates. (A)
are more than 0.0050 pmol/nmol organic phosphate but less than 0.040 pmol/
hosphate of isc1Δ whole cell. (D) Species which are more than 0.040 pmol/nmol
hate but less than 0.040 pmol/nmol organic phosphate, and (F) species which are
e mean values±SEM of lipid measurements from three independent cultures for
ndrial purifications for mitochondrial analysis.
Fig. 6. isc1Δ shows mitochondrial defects. (A) Petite ratio of isc1Δ. WT and
isc1Δ cells were inoculated at OD600 of 0.1 in YPD medium, incubated at 39
for the indicated times, and plated onto YPD plates. Small colonies that grew on
YPD plates were replica plated onto YPGE plates to confirm the inability to
grow on non-fermentable carbon medium, and the numbers of the colonies
which grew on YPD but not on YPGE plates were counted. Statistical
differences were evaluated by Student's unpaired t test and are indicated by
asterisks (⁎⁎pb0.01, ⁎pb0.12). (B) Hydrogen peroxide sensitivity of isc1Δ .
WT and isc1Δ were treated with 1 mM hydrogen peroxide for 45 min, plated
onto YPD and the formed colonies were counted. Statistical difference was
evaluated by Student's unpaired t test and is indicated by asterisks (⁎⁎pb0.01).
(C) Ethidium bromide sensitivity of isc1Δ. WT and isc1Δ cells were treated
with 50 μM ethidium bromide, and 5 μl of the suspension was spotted onto a
YPD plate with serial dilutions at 10 fold.
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colonies was measured. Fig. 6B demonstrates that the number
of colonies of WT cells treated with hydrogen peroxide was
58.0% of that of non-treated cells whereas the number of co-
lonies of isc1Δ cells treated with hydrogen peroxide was 41.2%
of that of non-treated cells, indicating that isc1Δ is significantly
sensitive to hydrogen peroxide relative to WT ( pb0.01).
Ethidium bromide has been reported to specifically damage
mitochondrial DNA, and mutants that have dysfunctional
mitochondria show altered sensitivity to this substance [41,42].
To elucidate if isc1Δ is sensitive to ethidium bromide, WT and
isc1Δ cells were treated with 50 μM ethidium bromide and
spotted onto a YPD plate. The results showed that isc1Δ was
more sensitive to ethidium bromide than WT (Fig. 6C).
Together, these results indicate that isc1Δ has defectivemitochondrial phenotypes and reveal a role of sphingolipid
in mitochondrial function in vivo.
4. Discussion
Data in this report reveal that Isc1p of S. cerevisiae localizes
to the outer membrane of mitochondria as an integral
membrane protein, and its activity is enriched in purified
mitochondria. Moreover, this study is the first to measure
α-hydroxylated ceramide species and to show that mitochon-
dria are highly enriched in very long chain α-hydroxylated
phytoceramides. Importantly isc1Δ showed an altered mito-
chondrial sphingolipid profile, indicating that Isc1p regulates
sphingolipid metabolism of mitochondria, especially the
formation of α-hydroxylated very long chain phytoceramides.
Finally, isc1Δ displayed defects in mitochondrial functions,
suggesting, for the first time, a role for mitochondrial
sphingolipid metabolism in mitochondrial metabolic function
in vivo.
Recent advances in methods for mitochondrial purification as
well as newly developed lipidomic strategies have enabled a
more comprehensive and precise assessment of simple sphingo-
lipids in mitochondria of S. cerevisiae. Previous data indicated
that mitochondria contain 7.4% of the total complex sphingo-
lipid content, with an additional 30% in plasma membrane [10].
Another report demonstrated that mitochondria contain 4.6 nmol
of IPC/mg protein, 7.7 nmol of MIPC/mg protein and 5.6 nmol
of M(IP)2C/mg protein, while plasma membrane contains
34.9 nmol of IPC/mg protein, 69.9 nmol of MIPC/mg protein
and 120.5 nmol of M(IP)2C/mg protein [9]. It is important to
note, however, that the mitochondrial fractions used for these
studies were not derived from density gradient centrifugation,
and thus, it is difficult to know the degree of contamination of
these preparations with microsomal membranes. Moreover, these
previous reports studied only complex sphingolipids and did not
address ceramides and sphingoid bases, the subjects of this study.
With this current analysis, it was found that mitochondria
from WT cells are highly enriched, and specifically, with very
long chain α-hydroxylated phytoceramides. This unexpected
result raises a number of questions as to the metabolism of very
long chain sphingolipids in yeast and their function. Very little is
known about the regulation of incorporation of very long chain
fatty acids into sphingolipids or the subcellular sites of migration
of these lipids. Both Lag1p and Lac1p ceramide synthases,
thought to reside in the ER, are capable of introducing very long
chain fatty acids into ceramides [43] which in turn are incor-
porated in IPC, MIPC, and M(IP)2C [44–47]. While the bulk of
these complex sphingolipids eventually arrives at the plasma
membrane, published results show that a significant component
of these lipids may reside in the mitochondria [9]. Together with
the current results that Isc1p is localized to the outer membrane
of mitochondria (Fig. 1) and mitochondria purified from isc1Δ
exhibit a lower content of α-hydroxylated phytoceramides than
that from WT (Fig. 5A), it is suggested that these complex
sphingolipids become substrates for Isc1p either at the outer
mitochondrial membrane or in a compartment that comes in
contact with the outer membrane (e.g. mitochondrial associated
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where and how Isc1p interacts with yeast complex sphingoli-
pids. Moreover, this study did not address the issue of topology
of Isc1p, and therefore, it is not known whether its active site
faces into the mitochondria or out of the mitochondria. This
proposal that sphingolipids are generated at the outer membrane
of mitochondria is also in agreement with the previous report
[48] that detected threefold enrichment of ceramide in the outer
membrane relative to the inner membrane of rat liver
mitochondria. Considering that Isc1p is activated by cardiolipin
and phosphatidylglycerol [26,29] and that these lipids are
synthesized in the inner membrane of mitochondria [49–51],
Isc1p may be activated at the membrane contact site of outer and
inner membrane [52,53]. Alternatively, up to 36.6% of
cardiolipin has been detected in the outer membrane of
mitochondria [54,55] and this could then activate Isc1p. Further
investigation is required for elucidation of pathways of
subcellular transport and metabolism of complex sphingolipids.
The results also showed that mitochondria are relatively
depleted in sphingoid bases, and this is consistent with the
known ER sites for de novo sphingolipid synthesis [56] or
ceramide degradation in the ER and Golgi [57,58].
The current results as well as previous results [29] impli-
cating Isc1p in regulation of metabolism of non-fermentable
carbon sources suggest a role for either the precursor sphin-
golipids and/or the generated α-hydroxylated phytoceramides
in regulating metabolic functions of mitochondria. These could
include signaling functions of the ceramides and/or structural
functions. The latter are consistent with the recent suggestion
that many mitochondrial proteins reside in ‘rafts’ [59].
Moreover, genome-wide analysis revealed that most of
ergosterol synthetic mutants showed defective mitochondrial
morphology [60]. Since, ergosterol has been reported to form
rafts together with sphingolipids [61] the results in this study
raise the possibility of sphingolipid/sterol structures/raft in the
function of mitochondria.
The specific ceramide generated by the action of Isc1p could
also play regulatory functions. In mammalian cells, ceramide,
exogenously added or generated endogenously by overexpres-
sion of mitochondrially-targeted sphingomyelinase, has been
shown to induce/regulate Bax translocation and to be involved in
mitochondrial dysfunction, such as increases in the permeability
of the outer membrane and release of cytochrome c
[13,15,17,62]. However, whether endogenous ceramides are
generated in eukaryotic mitochondria and exert effects on
mitochondria in vivo has not been well evaluated and has been
under significant discussion [63]. The results in this study show,
for the first time, that native alteration in sphingolipid
metabolism in mitochondria causes dysfunctions of mitochon-
dria in vivo, suggesting an intrinsic role of some specific
ceramide in regulating mitochondrial functions. However,
further studies are required for elucidation of sphingolipid-
mediated functions in yeast.
In conclusion, we have determined the submitochondrial
localization of Isc1p and its effect on mitochondrial sphingo-
lipid metabolism, and elucidated that isc1Δ exhibits mitochon-
dria-related phenotypes. The findings contribute key knowledgetoward complete understanding of the metabolism of mito-
chondrial sphingolipids and their roles in mitochondrial
function in eukaryotic cells.
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